CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Although there are changes in gene expression and alterations in neuronal density and afferent inputs in the forebrain of trisomic mouse models of Down syndrome (DS) and Alzheimer's disease (AD), there is a lack of systematic assessments of gene expression and encoded proteins within individual vulnerable cell populations, precluding translational investigations at the molecular and cellular level. Further, no effective treatment exists to combat intellectual disability and basal forebrain cholinergic neurodegeneration seen in DS. To further our understanding of gene expression changes before and following cholinergic degeneration in a well‐established mouse model of DS/AD, the Ts65Dn mouse, we assessed RNA expression levels from CA1 pyramidal neurons at two adult ages (∼6 months of age and ∼11 months of age) in both Ts65Dn and their normal disomic (2N) littermates. We further examined a therapeutic intervention, maternal choline supplementation (MCS), which has been previously shown to lessen dysfunction in spatial cognition and attention, and have protective effects on the survival of basal forebrain cholinergic neurons in the Ts65Dn mouse model. Results indicate that MCS normalized expression of several genes in key gene ontology categories, including synaptic plasticity, calcium signaling, and AD‐associated neurodegeneration related to amyloid‐beta peptide (Aβ) clearance. Specifically, normalized expression levels were found for endothelin converting enzyme‐2 (Ece2), insulin degrading enzyme (Ide), Dyrk1a, and calcium/calmodulin‐dependent protein kinase II (Camk2a), among other relevant genes. Single population expression profiling of vulnerable CA1 pyramidal neurons indicates that MCS is a viable therapeutic for long‐term reprogramming of key transcripts involved in neuronal signaling that are dysregulated in the trisomic mouse brain which have translational potential for DS and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand Sortilin
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z.-Y., Lee, F. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-04.2005 · Cited by 1,013 · cited 2×
“Further, p75NTR when bound to the precursor of NGF (proNGF) or the precursor to BDNF (proBDNF), can induce apoptosis (Mufson et al., 2012; Pedraza et al., 2005; Teng et al., 2005) indicating that upregulation of this receptor is potentially detrimental to neuronal health and survival.”
BackgroundA mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913 · cited 6×
“Ts65Dn mice mimic many key features of the human DS pathology, including hippocampaldependent learning and memory deficits (Ash et al., 2014; Escorihuela et al., 1995; Hyde & Crnic, 2001; Reeves et al., 1995; Velazquez et al., 2013), attentional deficits (Moon et al.”
BackgroundInfluentialInsulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561 · cited 1×
“…degeneration of cholinergic basal forebrain (CBF) neurons, and early endosomal abnormalities (Cataldo et al., 2000; Hartley et al., 2015; Hartley et al., 2014; Lai & Williams, 1989; Leverenz & Raskind, 1998; Mann, Yates, Marcyniuk, & Ravindra, 1986; Sendera et al., 2000; Wisniewski et al., 1985).”
BackgroundKleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · cited 1×
“Glutamatergic neurotransmission dysfunction, including impaired hippocampal long-term potentiation and enhanced long-term depression, has been observed in trisomic mice (Kaur et al., 2014; Kleschevnikov et al., 2004; Rueda et al., 2010; Siarey et al., 1999).”
BackgroundCorrelation and Large-Scale Simultaneous Significance Testing
Efron, B. (2007) · Journal of the American Statistical Association · doi:10.1198/016214506000001211 · Cited by 405
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 3×
“, 2003), but after 6 months of age (MO), Ts65Dn mice have significant BFCN and associated CA1 hippocampal degeneration, along with astrocytic hypertrophy, and microglial activation (Cooper et al., 2001; Granholm et al., 2000; Holtzman et al., 1996; Kelley et al., 2014b; Seo & Isacson, 2005).”
BackgroundSynaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297 · cited 1×
“…and Ts65Dn mice recapitulate aspects of this vulnerability through reduced hippocampal neurogenesis, synapse loss, and deficits in neuroplasticity (Belichenko et al., 2004, 2009; Granholm et al., 2003; Insausti et al., 1998; Kelley et al., 2014a, 2016; Kleschevnikov et al., 2012; Kurt, Davies,…”
BackgroundDown syndrome and Alzheimer's disease: common pathways, common goals
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290 · cited 2×
“…neurofibrillary tangles (NFTs), degeneration of cholinergic basal forebrain (CBF) neurons, and early endosomal abnormalities (Cataldo et al., 2000; Hartley et al., 2015; Hartley et al., 2014; Lai & Williams, 1989; Leverenz & Raskind, 1998; Mann, Yates, Marcyniuk, & Ravindra, 1986; Sendera et…”
BackgroundDetopoulou, P., Panagiotakos, D. B., Antonopoulou, S., Pitsavos, C., & Stefanadis, C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.424 · Cited by 286
Kimura, R., Kamino, K., Yamamoto, M., Nuripa, A., Kida, T., Kazui, H., Hashimoto, R., Tanaka, T., Kudo, T., Yamagata, H., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl437 · Cited by 281 · cited 2×
“Dyrk1a is upregulated in DS and AD (Ferrer et al., 2005; Kimura et al., 2007; Lockstone et al., 2007), may dysregulate the 3-repeat tau to 4-repeat tau ratio (Wegiel, Gong, & Hwang, 2011), and is part of the triplicated “DS critical region” that has been implicated in cognitive impairment in DS.”
BackgroundKahlem, P., Sultan, M., Herwig, R., Steinfath, M., Balzereit, D., Eppens, B., Saran, N. G., Pletcher, M. T., South, S. T., Stetten, G., et al. (2004) · Genome Research · doi:10.1101/gr.1951304 · Cited by 249 · cited 2×
“…mouse chromosome 17 (MMU17) orthologous to HSA21 to <10% of the centromere of MMU17, creating a freely segregating chromosome (Akeson et al., 2001; Kahlem et al., 2004; Reeves et al., 1995) with a conservation of 70% homology for >85 protein coding gene sequences, with over 250 genes and putative…”
BackgroundCataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 1×
“The well-established segmental trisomy Ts65Dn mouse model closely replicates human DS neuropathology (Cataldo et al., 2003; Davisson et al., 1993; Granholm, Sanders, & Crnic, 2000; Holtzman et al., 1996; Salehi et al., 2006; Seo & Isacson, 2005).”
BackgroundGene expression profiling in the adult Down syndrome brain
Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.005 · Cited by 240 · cited 1×
“Dyrk1a is upregulated in DS and AD (Ferrer et al., 2005; Kimura et al., 2007; Lockstone et al., 2007), may dysregulate the 3-repeat tau to 4-repeat tau ratio (Wegiel, Gong, & Hwang, 2011), and is part of the triplicated “DS critical region” that has been implicated in cognitive impairment in DS.…”
BackgroundKim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., Norton, D., Tesco, G., Elliott, K., Wagner, S. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp323 · Cited by 234
Neurological phenotypes for Down syndrome across the life span
Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225 · cited 1×
“DS is also the primary genetic cause of intellectual disability (ID), with cognitive deficits in hippocampal-dependent learning and memory, attention, and language and communication skills (Chapman & Hesketh, 2000; Esbensen, 2010; Lott, 2012; Rachidi & Lopes, 2008, 2010).”
BackgroundDuchon, A., Raveau, M., Chevalier, C., Nalesso, V., Sharp, A. J., & Herault, Y. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9356-0 · Cited by 224
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome
Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184 · cited 1×
“Glutamatergic neurotransmission dysfunction, including impaired hippocampal long-term potentiation and enhanced long-term depression, has been observed in trisomic mice (Kaur et al., 2014; Kleschevnikov et al., 2004; Rueda et al., 2010; Siarey et al., 1999).”
BackgroundMehedint, M. G., Niculescu, M. D., Craciunescu, C. N., & Zeisel, S. H. (2010) · The FASEB Journal · doi:10.1096/fj.09-140145 · Cited by 167
Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome.
Insausti, A. M., Megı́as, M., Crespo, D., Cruz-Orive, L. M., Dierssen, M., Vallina, T. F., Insausti, R., & Flórez, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00641-7 · Cited by 149 · cited 2×
“The septohippocampal circuit is vulnerable in both DS and AD, and Ts65Dn mice recapitulate aspects of this vulnerability through reduced hippocampal neurogenesis, synapse loss, and deficits in neuroplasticity (Belichenko et al., 2004, 2009; Granholm et al., 2003; Insausti et al., 1998; Kelley et al., 2014a, 2016; Kles…”
BackgroundCavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133 · cited 1×
“Conversely, upregulation of Mapk13 results in increased immune system activation and tau phosphorylation (Cavallini et al., 2013; Feijoo, Campbell, Jakes, Goedert, & Cuenda, 2005; Risco et al., 2012).”
BackgroundFeijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133
Ross, R. G., Hunter, S. K., Hoffman, M. C., McCarthy, L., Chambers, B. M., Law, A. J., Leonard, S., Zerbe, G. O., & Freedman, R. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15091188 · Cited by 123 · cited 2×
“, 2017) and behavioral and morphologic benefits in several models of neurodevelopmental disorders (Bearer, Wellmann, Tang, He, & Mooney, 2015; Ross et al., 2016; Scremin, Roch, Norman, Djazayeri, & Liu, 2015; Stevens et al., 2008; Ward, Agarwal, Wang, Berger-Sweeney, & Kolodny, 2008; Kolodny, Nag, & Berger-Sweeney, 20…”
BackgroundTranscript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions
Sturgeon, X., & Gardiner, K. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9321-y · Cited by 117 · cited 5×
“This model translocates a segment of mouse chromosome 16 (MMU16) and mouse chromosome 17 (MMU17) orthologous to HSA21 to <10% of the centromere of MMU17, creating a freely segregating chromosome (Akeson et al., 2001; Kahlem et al., 2004; Reeves et al., 1995) with a conservation of 70% homology for >85 protein coding g…”
BackgroundInfluentialZhu, K., Xiang, X., Filser, S., Marinković, P., Dorostkar, M. M., Crux, S., Neumann, U., Shimshek, D. R., Rammes, G., Haass, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.023 · Cited by 107 · cited 1×
“Alternatively, Bace1 deficiency may be considered detrimental, as a loss of Bace1 expression impairs myelination (Hu, Hu, Dai, Trapp, & Yan, 2015) and causes hippocampal synaptic deficits (Petrus & Lee, 2014; Wang et al., 2014; Zhu et al., 2016), illustrating the need for normative Bace1 levels.”
BackgroundGarcía-Cerro, S., Martínez, P., Vidal, V., Corrales, A., Flórez, J., Vidal, R., Rueda, N., Arbonés, M. L., & Martínez-Cué, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106572 · Cited by 104
Altafaj, X., Martín, E. D., Ortiz-Abalia, J., Valderrama, A., Lao-Peregrín, C., Dierssen, M., & Fillat, C. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.017 · Cited by 75
Synaptophysin and Synaptojanin-1 in Down Syndrome are Differentially Affected by Alzheimer's Disease
Martin, S. B., Dowling, A. L. S., Lianekhammy, J., Lott, I. T., Doran, E., Murphy, M. P., Beckett, T. L., Schmitt, F. A., & Head, E. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140795 · Cited by 64 · cited 2×
“We found that Synj1 expression levels are normalized by MCS. Upregulation of Synj1 has been linked to increases in Ab and endosomal abnormalities in DS (Cossec et al., 2012; Martin et al., 2014; Zhu et al., 2013).”
BackgroundKaur, G., Sharma, A., Xu, W., Gerum, S., Alldred, M. J., Subbanna, S., Basavarajappa, B. S., Pawlik, M., Ohno, M., Ginsberg, S. D., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5338-13.2014 · Cited by 58 · cited 1×
“Glutamatergic neurotransmission dysfunction, including impaired hippocampal long-term potentiation and enhanced long-term depression, has been observed in trisomic mice (Kaur et al., 2014; Kleschevnikov et al., 2004; Rueda et al., 2010; Siarey et al., 1999).”
BackgroundSelf-citationBACE1 Is Necessary for Experience-Dependent Homeostatic Synaptic Plasticity in Visual Cortex
Petrus, E., & Lee, H.-K. (2014) · Neural Plasticity · doi:10.1155/2014/128631 · Cited by 19 · cited 1×
“Alternatively, Bace1 deficiency may be considered detrimental, as a loss of Bace1 expression impairs myelination (Hu, Hu, Dai, Trapp, & Yan, 2015) and causes hippocampal synaptic deficits (Petrus & Lee, 2014; Wang et al., 2014; Zhu et al., 2016), illustrating the need for normative Bace1 levels.”
BackgroundZeisel, S. H. (2010) · Journal of Nutrigenetics and Nutrigenomics · doi:10.1159/000324357 · Cited by 9 · cited 3×
“In addition, choline is a key substrate of the phosphatidylethanolamineN-methyltransferase (PEMT) pathway, which generates phosphatidylcholine species, crucial elements in neuronal and non-neuronal lipid membranes (Lindblom & Oradd, 2009; Wang, Megill, Wong, Kirkwood, & Lee, 2016; Zeisel, 2010; Zeisel & Niculescu, 200…”
Background
Cited by
Role of Cholinergic Signaling in Alzheimer’s Disease
Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F. (2022) · Molecules · doi:10.3390/molecules27061816 · Cited by 922
D’Acunzo, P., Pérez-González, R., Kim, Y., Hargash, T., Miller, C., Alldred, M. J., Erdjument-Bromage, H., Penikalapati, S. C., Pawlik, M., Saito, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe5085 · Cited by 280
Self-citationAtas-Ozcan, H., Brault, V., Duchon, A., & Herault, Y. (2021) · Genes · doi:10.3390/genes12111833 · Cited by 78
“Finally, DYRK1A also phosphorylates the Aβ degradation enzymes neprilysin (NEP) and the insulin degrading enzyme IDE, decreasing their activity [138,140].”
BackgroundFreeburn, A., & Munn, R. G. K. (2021) · Neuronal Signaling · doi:10.1042/ns20200011 · Cited by 37
Metadata
- Authors
- Alldred, M. J., Chao, H. M., Lee, S. H., Beilin, J., Powers, B. E., Petkova, E., Strupp, B. J., & Ginsberg, S. D.
- Venue
- Hippocampus
- Publisher
- Wiley
- Published
- 2018-02-12
- Volume
- 28
- Issue
- 4
- Pages
- 251-268
- ISSN
- 1050-9631 (ISSN-L)
- 1098-1063
- OpenAlex
- W2793107236
- Cited by
- 35
- References
- 34
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.